Anti-FLT3 CAR T-cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anti-FLT3 CAR T-cell therapy, covering 2021-12-30 to 2021-12-30. Get the full timeline:
Most recent: Clinical Trial Update: Anti-FLT3 CAR T-cell Therapy in FLT3 Positive Relapsed/Refractory Acute Myeloid Leukemia [Phase 1, Phase 2]